EFPIA and others welcome EC's work on biosimilar access

Groups representing Europe’s pharma, biotech and generics companies have welcomed the European Commission’s staging of a workshop on the uptake of biosimilars.

The European Union’s executive arm invited patients, doctors, pharmacists, academics, authorities, press and industry members to the workshop to share experiences with biosimilar medicines across the continent.

This activity has been praised in a joint statement from EFPIA (European Federation of Pharmaceutical Industries and Associations), EuropaBio and Medicines for Europe, trade groups which represent the pharma, biotech and generics sectors respectively.